Can SPET imaging of dopamine uptake sites replace PET imaging in Parkinson's disease? For.
Tatsch
Klaus
K
Department of Nuclear Medicine, Klinikum Grosshadern, Ludwig-Maximilians-University Munich, Marchioninistrasse 15, 81377 Munich, Germany. tatsch@nuk.med.uni-muenchen.de
D001921:Brain / Q000000981:diagnostic imaging / Q000378:metabolism; D018450:Disease Progression; D004298:Dopamine / Q000378:metabolism*; D050483:Dopamine Plasma Membrane Transport Proteins; D005462:Fluorine Radioisotopes / Q000493:pharmacokinetics; D006801:Humans; D008562:Membrane Glycoproteins; D026901:Membrane Transport Proteins / Q000378:metabolism; D009419:Nerve Tissue Proteins; D010300:Parkinson Disease / Q000000981:diagnostic imaging* / Q000378:metabolism*; D014055:Tomography, Emission-Computed / Q000295:instrumentation / Q000379:methods; D015899:Tomography, Emission-Computed, Single-Photon / Q000295:instrumentation / Q000379:methods*
D050483:Dopamine Plasma Membrane Transport Proteins; D005462:Fluorine Radioisotopes; D008562:Membrane Glycoproteins; D026901:Membrane Transport Proteins; D009419:Nerve Tissue Proteins; D004298:Dopamine